Imetit
Imetit je agonist histaminskog H3 receptora.[3]
Nazivi | |
---|---|
IUPAC naziv
2-(1H-imidazol-5-il)etil imidotiokarbamat
| |
Identifikacija | |
3D model (Jmol)
|
|
ChemSpider | |
| |
Svojstva | |
C6H10N4S | |
Molarna masa | 170,2354 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
verifikuj (šta je ?) | |
Reference infokutije | |
Reference уреди
- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Garbarg, M; Arrang, JM; Rouleau, A; Ligneau, X; Tuong, MD; Schwartz, JC; Ganellin, CR (1992). „S-2-(4-imidazolyl)ethylisothiourea, a highly specific and potent histamine H3 receptor agonist”. The Journal of Pharmacology and Experimental Therapeutics. 263 (1): 304—10. PMID 1383495.